A

Armata Pharmaceuticals Inc
F:TG1N

Watchlist Manager
Armata Pharmaceuticals Inc
F:TG1N
Watchlist
Price: 5.3 EUR 2.91% Market Closed
Market Cap: 191.6m EUR

Wall Street
Price Targets

TG1N Price Targets Summary
Armata Pharmaceuticals Inc

Wall Street analysts forecast TG1N stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TG1N is 7.8 EUR with a low forecast of 7.73 EUR and a high forecast of 8.03 EUR.

Lowest
Price Target
7.73 EUR
46% Upside
Average
Price Target
7.8 EUR
47% Upside
Highest
Price Target
8.03 EUR
52% Upside
Armata Pharmaceuticals Inc Competitors:
Price Targets
6855
Ascentage Pharma Group International
97% Upside
CGON
CG Oncology Inc
83% Upside
COV
Covalon Technologies Ltd
75% Upside
EDT
Spectral Medical Inc
143% Upside
2616
CStone Pharmaceuticals
153% Upside
CELC
Celcuity Inc
11% Upside
INCY
Incyte Corp
2% Upside
ADAG
Adagene Inc
426% Upside

Revenue
Forecast

Revenue Estimate
Armata Pharmaceuticals Inc

For the last 12 years the compound annual growth rate for Armata Pharmaceuticals Inc's revenue is 19%.

19%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Armata Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Armata Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TG1N's stock price target?
Price Target
7.8 EUR

According to Wall Street analysts, the average 1-year price target for TG1N is 7.8 EUR with a low forecast of 7.73 EUR and a high forecast of 8.03 EUR.

Back to Top